# Integrated Phosphoproteomics Identifies TGFβ-Dependent Phosphorylation Events Linking Kinase Signaling to Autophagy in Palatogenesis

**Authors:** Xia Peng, Jing Chen, Xiaoyu Zheng, Xige Zhao, Yijia Wang, Xiaotong Wang, Juan Du

PMC · DOI: 10.3390/proteomes14010005 · Proteomes · 2026-01-23

## TL;DR

This study explores how TGFβ signaling influences autophagy during palate development by analyzing phosphorylation events in mouse cells.

## Contribution

The study identifies novel TGFβ-dependent phosphorylation events and a new role for CSNK2A in regulating phospho-signaling during palatogenesis.

## Key findings

- TGFβ2 treatment altered the MEPM phosphoproteome, with 477 upregulated and 53 downregulated phosphopeptides.
- Seven serine and one threonine phosphorylation motifs were enriched in TGFβ2-treated cells.
- CSNK2A, MAPKs, and CDKs were identified as key regulators of TGFβ-dependent phosphorylation.

## Abstract

Background: Cleft palate (CP) is a prevalent craniofacial malformation, with the TGFβ pathway playing a critical role. Recent evidence links autophagy to regulating mouse embryonic palatal mesenchyme (MEPM) cells, but its interaction with TGFβ-activated phosphorylation cascades remains largely unknown. Here, we investigated the interplay between these pathways during palatogenesis. Methods: H&E and IHC analyses revealed increased expression of Beclin 1 and LC3 during the critical period of palatal shelf elevation and fusion (E13.5–E15.5). Bulk RNA sequencing (Bulk RNA-seq) further revealed enrichment of autophagy-related pathways and their interaction with TGFβ signaling. TMT-based phosphoproteomics was performed on TGFβ2-treated MEPM cells. Results: We identified 23,471 peptides and 3952 proteins, including 6339 phosphopeptides corresponding to 2195 phosphoproteins. Differential analysis found 477 phosphopeptides with increased abundance and 53 with decreased abundance, revealing the enrichment of seven serine (p-Ser) motifs (RxxS, SDxD, SDxE, SP, SxDE, SxEE, SxxxxD) and one threonine (p-Thr) motif (TP). Notably, kinase-substrate enrichment analysis identified CSNK2A as a previously unrecognized phosphorylation regulator, together with MAPKs and CDKs. Functional enrichment showed significant involvement of mTOR, MAPK, and autophagy/mitophagy pathways. Conclusions: Our findings revealed that TGFβ2 reshapes the MEPM phosphoproteome through Smad-independent pathway, expanding the palate-specific phospho-signaling atlas beyond the canonical Smad cascade.

## Linked entities

- **Genes:** BECN1 (beclin 1) [NCBI Gene 8678], MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557]
- **Proteins:** MAP1LC3A (microtubule associated protein 1 light chain 3 alpha)
- **Diseases:** cleft palate (MONDO:0016064)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mapk3 (mitogen-activated protein kinase 3) [NCBI Gene 26417] {aka Erk-1, Erk1, Ert2, Esrk1, Mnk1, Mtap2k}, Csl (citrate synthase like) [NCBI Gene 71832] {aka 1700007H16Rik}, Stard10 (StAR related lipid transfer domain containing 10) [NCBI Gene 56018] {aka CGI-52, NY-C0-28, PC-TP2, PCTP2, Pctpl, Sdccag28}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, TGFB2 (transforming growth factor beta 2) [NCBI Gene 7042] {aka CAEND2, G-TSF, LDS4, TGF-beta2}, Pten (phosphatase and tensin homolog) [NCBI Gene 19211] {aka 2310035O07Rik, A130070J02Rik, B430203M17Rik, MMAC1, PTENbeta, TEP1}, Ptges3 (prostaglandin E synthase 3) [NCBI Gene 56351] {aka 5730442A20Rik, Ptges, Tebp, cPGES, p23, sid3177}, Dkc1 (dyskeratosis congenita 1, dyskerin) [NCBI Gene 245474], Tgfbr1 (transforming growth factor, beta receptor I) [NCBI Gene 21812] {aka ALK5, Alk-5, ESK2, TGFR-1, TbetaR-I, TbetaRI}, Becn1 (beclin 1, autophagy related) [NCBI Gene 56208] {aka Atg6}, Atg16l1 (autophagy related 16 like 1) [NCBI Gene 77040] {aka 1500009K01Rik, Apg16l, Atg16l, WDR30}, Foxk1 (forkhead box K1) [NCBI Gene 17425] {aka A630048H08Rik, Gm10868, Mnf}, Mapk10 (mitogen-activated protein kinase 10) [NCBI Gene 26414] {aka C230008H04Rik, JNK3, JNK3B1, JNK3B2, SAPK(beta), Serk2}, Ppp1r2 (protein phosphatase 1, regulatory inhibitor subunit 2) [NCBI Gene 66849] {aka 0610025N14Rik, 2310007G06Rik, 4930440J04Rik, 5430408E15Rik, D16Ertd248e, I-2}, Ulk1 (unc-51 like kinase 1) [NCBI Gene 22241] {aka Unc51.1, mKIAA0722}, Atg10 (autophagy related 10) [NCBI Gene 66795] {aka 5330424L23Rik, 5430428K15Rik, APG10, Agp10, Apg10l, Apg10p}, Eif4b (eukaryotic translation initiation factor 4B) [NCBI Gene 75705] {aka 2310046H11Rik, Eif4a2}, Prkaa1 (protein kinase, AMP-activated, alpha 1 catalytic subunit) [NCBI Gene 105787] {aka AMPKalpha1, C130083N04Rik}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Rictor (RPTOR independent companion of MTOR, complex 2) [NCBI Gene 78757] {aka 4921505C17Rik, 6030405M08Rik, AVO3, D530039E11Rik}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Clip1 (CAP-GLY domain containing linker protein 1) [NCBI Gene 56430] {aka 1110007I12Rik, 4631429H07Rik, CLIP-170, CLIP170, CYLN1, Clip50}, Mapk9 (mitogen-activated protein kinase 9) [NCBI Gene 26420] {aka JNK2, Prkm9, p54aSAPK}, Ddit3 (DNA-damage inducible transcript 3) [NCBI Gene 13198] {aka AltDDIT3, CHOP-10, CHOP10, chop, gadd153}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Mapk15 (mitogen-activated protein kinase 15) [NCBI Gene 332110] {aka ERK-8}, Map3k1 (mitogen-activated protein kinase kinase kinase 1) [NCBI Gene 26401] {aka MAPKKK1, MEKK1, Mekk}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16476] {aka AP-1, Junc, c-jun}, Map2k2 (mitogen-activated protein kinase kinase 2) [NCBI Gene 26396] {aka MEK2, MK2, Prkmk2}, Tgfb2 (transforming growth factor, beta 2) [NCBI Gene 21808] {aka Tgf-beta2, Tgfb-2}, Nup62 (nucleoporin 62) [NCBI Gene 18226] {aka D7Ertd649e, Nupc1, p62}, Akt1s1 (AKT1 substrate 1) [NCBI Gene 67605] {aka 1110012J22Rik, Lobe, Lobel, PRAS40}, Tff2 (trefoil factor 2 (spasmolytic protein 1)) [NCBI Gene 21785] {aka SP, mSP}, Nfatc4 (nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4) [NCBI Gene 73181] {aka 3110041H08Rik, Nfat3}, Atg5 (autophagy related 5) [NCBI Gene 11793] {aka 2010107M05Rik, 3110067M24Rik, Apg5l, Atg5l, Paddy}, Ep300 (E1A binding protein p300) [NCBI Gene 328572] {aka A430090G16, A730011L11, KAT3B, p300, p300 HAT}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, TGFB3 (transforming growth factor beta 3) [NCBI Gene 7043] {aka ARVD, ARVD1, LDS5, RNHF, TGF-beta3}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Lamp2 (lysosomal-associated membrane protein 2) [NCBI Gene 16784] {aka CD107b, LGP-B, Lamp II, Lamp-2, Lamp-2a, Lamp-2b}, Mcm2 (minichromosome maintenance complex component 2) [NCBI Gene 17216] {aka BM28, CDCL1, Mcmd2, mKIAA0030}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 26419] {aka JNK, JNK1, Prkm8, SAPK1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Crtc2 (CREB regulated transcription coactivator 2) [NCBI Gene 74343] {aka 4632407F12Rik, Torc2}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Top2a (topoisomerase (DNA) II alpha) [NCBI Gene 21973] {aka Top-2}, Lamtor1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1) [NCBI Gene 66508] {aka 2400001E08Rik, Pdro, p18}, Grk2 (G protein-coupled receptor kinase 2) [NCBI Gene 110355] {aka Adrbk-1, Adrbk1, Bark-1, beta ARK, betaARK1}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Cdk7 (cyclin dependent kinase 7) [NCBI Gene 12572] {aka C230069N13, CAK, Cdkn7, Crk4, P39 Mo15}, Hsp90ab1 (heat shock protein 90 alpha (cytosolic), class B member 1) [NCBI Gene 15516] {aka 90kDa, Hsp84, Hsp84-1, Hsp90, Hspcb}, Fosl2 (fos-like antigen 2) [NCBI Gene 14284] {aka Fra-2}, Rps6 (ribosomal protein S6) [NCBI Gene 20104] {aka S6R}, Map3k20 (mitogen-activated protein kinase kinase kinase 20) [NCBI Gene 65964] {aka B230120H23Rik, HCCS-4, MLTK, MLTKalpha, MLTKbeta, MRK}, Gnrh1 (gonadotropin releasing hormone 1) [NCBI Gene 14714] {aka Gnrh, Gnrh2, LHRH, Lhrh1, Lnrh, hpg}, Egfr (epidermal growth factor receptor) [NCBI Gene 13649] {aka 9030024J15Rik, Erbb, Errb1, Errp, Wa5, wa-2}, Pdcd5 (programmed cell death 5) [NCBI Gene 56330] {aka 2200003D22Rik, Tfar19}
- **Diseases:** craniofacial anomaly (MESH:D019465), CP (MESH:D002972), pregnancy failure (MESH:D051437), colorectal cancer (MESH:D015179), congenital malformations (OMIM:163000), inflammatory (MESH:D007249), injury to (MESH:D014947), MEPM (MESH:D004482), acute myeloid leukemia (MESH:D015470), malformations (MESH:C564254), dislocation (MESH:D004204), developmental disorders (MESH:D002658), hematologic and solid malignancies (MESH:D019337), fetal developmental disorders (MESH:D005315), weight gain (MESH:D015430), intrauterine hemorrhage (MESH:D006470)
- **Chemicals:** serine (MESH:D012694), TFA (MESH:D014269), acetonitrile (MESH:C032159), nicotine (MESH:D009538), rapamycin (MESH:D020123), balsam (MESH:D001453), streptomycin (MESH:D013307), xylene (MESH:D014992), amino acid (MESH:D000596), Heme (MESH:D006418), EDTA (MESH:D004492), formic acid (MESH:C030544), sodium citrate (MESH:D000077559), hematoxylin (MESH:D006416), penicillin (MESH:D010406), ammonia (MESH:D000641), Phosphopeptide (MESH:D010748), Paraffin (MESH:D010232), DAPPs (-), H&amp;E (MESH:D006371), CX-4945 (MESH:C555142), ethanol (MESH:D000431), Fe-NTA (MESH:C020326), CQ (MESH:D002738), threonine (MESH:D013912), eosin (MESH:D004801), alcohol (MESH:D000438), SDS (MESH:D012967), PFA (MESH:C003043), Peptide (MESH:D010455), water (MESH:D014867), imidazole (MESH:C029899), tyrosine (MESH:D014443), TiO2 (MESH:C009495), CO2 (MESH:D002245)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Porphyromonas gingivalis (species) [taxon 837]
- **Mutations:** serine/threonine, ATG9A
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), E13.5 — Mus musculus (Mouse), Hybridoma (CVCL_A0MS), MEPM — Homo sapiens (Human), Finite cell line (CVCL_2486)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921946/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921946/full.md

## References

82 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921946/full.md

---
Source: https://tomesphere.com/paper/PMC12921946